Genomma Lab Internacional, S.A.B. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.
The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions. Flagship offerings include topical pain relievers, anti‐acne skincare, hair restoration treatments and hygiene products designed for broad retail distribution. By focusing on categories with sustained consumer demand, Genomma Lab has cultivated strong brand recognition in its core markets.
Genomma Lab serves a geographic footprint that extends beyond Mexico to the United States, Central America and South America. It operates manufacturing facilities in Mexico and leverages third‐party partners to streamline production and logistics. Products are distributed through pharmacies, supermarkets, mass merchandisers and e-commerce channels, enabling the company to maintain a multi-channel presence and respond rapidly to market trends.
After debuting on the Mexican Stock Exchange in 2006, Genomma Lab expanded its capital markets profile by beginning trade of American Depositary Receipts on the U.S. over-the-counter market under the ticker GNMLF. Over its history, the company has pursued strategic acquisitions and brand extensions to reinforce its position as a leading OTC and personal care specialist in Latin America and select U.S. markets.
AI Generated. May Contain Errors.
Free GNMLF Stock Alerts